Khindivi

Adult Dosing .

Dosage forms:  --

New FDA Approval: May 2025

[Adult dosing is not applicable for this drug]

Peds Dosing .

Dosage forms:  SOL: 1 mg per mL

New FDA Approval: May 2025

[content coming soon]

adrenal insufficiency, chronic

[content coming soon]

Info: exact mechanism of anti-inflammatory action unknown; inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects

congenital adrenal hyperplasia

[content coming soon]

Info: exact mechanism of anti-inflammatory action unknown; inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects